We are live on ! Find out more
IC

Iconiq Capital Portfolio holdings

AUM $4.46B
1-Year Est. Return 22.86%
This Fund
S&P 500
This Quarter Est. Return
+1.62%
1 Year Est. Return
-22.86%
3 Year Est. Return
+2.92%
5 Year Est. Return
-21.42%
10 Year Est. Return
+423.18%
AUM
$970M
AUM Growth
-$33.4M
Cap. Flow
-$43.2M
Cap. Flow %
-4.46%
Top 10 Hldgs %
87.18%
Holding
64
New
5
Increased
13
Reduced
10
Closed
3

Top Buys

Rank Stock Value
1
NAGE
Niagen Bioscience
NAGE
+$9.22M
2
AAPL icon
Apple
AAPL
+$4.12M
3
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$3.06M
4
ARI
Apollo Commercial Real Estate
ARI
+$1.51M
5
VTI icon
Vanguard Total Stock Market ETF
VTI
+$1.47M

Top Sells

Rank Stock Value
1
BL icon
BlackLine
BL
+$50.7M
2
DVY icon
iShares Select Dividend ETF
DVY
+$7.52M
3
BABA icon
Alibaba
BABA
+$2.83M
4
GLD icon
SPDR Gold Trust
GLD
+$2.47M
5
KKR icon
KKR & Co
KKR
+$1.29M

Sector Composition

Rank Sector Weight
1 Technology 32.08%
2 Consumer Discretionary 14.84%
3 Communication Services 7.08%
4 Healthcare 1.04%
5 Consumer Staples 0.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOG icon
51
Alphabet (Google) Class C
GOOG
$4.3T
$315K 0.03%
6,020
+120
+2% +$6.11K
AKAO
52
DELISTED
Achaogen Inc
AKAO
$307K 0.03%
28,629
– –
VEU icon
53
Vanguard FTSE All-World ex-US ETF
VEU
$65.5B
$306K 0.03%
5,591
– –
CVX icon
54
Chevron
CVX
$379B
$304K 0.03%
2,432
+32
+1% +$3.79K
IDV icon
55
iShares International Select Dividend ETF
IDV
$8.16B
$256K 0.03%
7,576
– –
EPD icon
56
Enterprise Products Partners
EPD
$84B
$230K 0.02%
8,670
-1,324
-13% -$33.5K
IGSB icon
57
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.9B
$214K 0.02%
4,090
– –
CALA
58
DELISTED
Calithera Biosciences, Inc
CALA
$194K 0.02%
1,161
– –
OCIP
59
DELISTED
OCI Partners LP
OCIP
$144K 0.01%
17,835
– –
VIVS
60
VivoSim Labs
VIVS
$1.77M
$18K ﹤0.01%
55
– –
GEN
61
DELISTED
Genesis Healthcare, Inc.
GEN
$9K ﹤0.01%
11,500
– –
KKR icon
62
KKR & Co
KKR
$87.6B
– –
-63,290
Closed -$1.29M
PARR icon
63
Par Pacific Holdings
PARR
$3.94B
– –
-23,842
Closed -$496K
PXD
64
DELISTED
Pioneer Natural Resource Co.
PXD
– –
-1,369
Closed -$202K
1 2
3

Similar funds

GIBU
Gulf International Bank (UK) London, United Kingdom $4.47B AUM 29.35% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
TI
Truepoint Inc Cincinnati, Ohio $4.48B AUM 13.76% 1-Year Est. Return
JRP
Jasper Ridge Partners Menlo Park, California $4.49B AUM 18.72% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
BAAM
Baker Avenue Asset Management San Francisco, California $4.43B AUM 26.6% 1-Year Est. Return
CAU
Caxton Associates (UK) London $4.42B AUM 49.83% 1-Year Est. Return
DK
DJE Kapital 82049 Pullach, Germany $4.51B AUM 49.55% 1-Year Est. Return

Iconiq Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Iconiq Capital held 64 positions worth $970M, down 3.3% from $1B the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Iconiq Capital withdrew a net $43.2M in Q4 2017, closing 3 positions and reducing 10 holdings. Its most notable exit was KKR & Co, an estimated $1.29M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Iconiq Capital opened a new position in Niagen Bioscience worth $10M.

  • Iconiq Capital's largest Q4 2017 buy was Niagen Bioscience: 1,707,317 shares worth $10M.
  • Iconiq Capital added most to Apple in Q4 2017, an estimated $4.12M increase.
  • Iconiq Capital's biggest Q4 2017 reduction was BlackLine, cutting an estimated $50.7M.
  • Iconiq Capital fully exited KKR & Co in Q4 2017, selling an estimated $1.29M.
  • Iconiq Capital's ten largest holdings make up 87% of its $970M portfolio in Q4 2017.
  • Iconiq Capital opened 5 new positions and closed 3 in Q4 2017.
  • Iconiq Capital's portfolio value fell 3.3% quarter-over-quarter to $970M.

Based on Iconiq Capital's 13F filing for Q4 2017, filed 14 Feb 2018.